OCC 2.56% 40.0¢ orthocell limited

1. Because the prospects of their other products appear superior...

  1. 4,834 Posts.
    lightbulb Created with Sketch. 879
    1. Because the prospects of their other products appear superior
    2. Because they didn't have the funds without horrible dilution
    3. Because their partner has a distribution network they will never, ever, ever have
    4. Because competitors would have overtaken them before they made breakeven
    5. Because now they have the funds to execute their other products
    6. Because they will still get the revenue stream from STRIATE manufacture
    7. Because all this has the potential to make them into a profitable, self-funding company with huge prospects

    For all the talk about "the next CSL" on every other bio thread I think these guys are doing ok. Just wait until we see that up front cash AND the revenue stream start to kick in.
    Last edited by optimistus: 08/07/22
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.010(2.56%)
Mkt cap ! $83.83M
Open High Low Value Volume
39.0¢ 40.0¢ 39.0¢ $199.1K 504.6K

Buyers (Bids)

No. Vol. Price($)
1 3807 39.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 3666 2
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.